Cephalon Tries To Quash FTC Pay-For-Delay Suit

Cephalon Inc. has asked a federal judge to dismiss the Federal Trade Commission's ongoing antitrust suit alleging that the drugmaker illegally paid off generics competitors in a reverse payment agreement over...

Already a subscriber? Click here to view full article